86 related articles for article (PubMed ID: 9036950)
1. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
Lee YJ; Han Y; Lu HT; Nguyen V; Qin H; Howe PH; Hocevar BA; Boss JM; Ransohoff RM; Benveniste EN
J Immunol; 1997 Mar; 158(5):2065-75. PubMed ID: 9036950
[TBL] [Abstract][Full Text] [Related]
2. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon.
Gao J; De BP; Han Y; Choudhary S; Ransohoff R; Banerjee AK
J Virol; 2001 Feb; 75(3):1124-31. PubMed ID: 11152485
[TBL] [Abstract][Full Text] [Related]
3. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Darley R; Morris A; Passas J; Bateman W
Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator.
Kretsovali A; Agalioti T; Spilianakis C; Tzortzakaki E; Merika M; Papamatheakis J
Mol Cell Biol; 1998 Nov; 18(11):6777-83. PubMed ID: 9774691
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.
Panelli MC; Wang E; Shen S; Schluter SF; Bernstein RM; Hersh EM; Stopeck A; Gangavalli R; Barber J; Jolly D; Akporiaye ET
Cancer Immunol Immunother; 1996 Feb; 42(2):99-107. PubMed ID: 8620527
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 regulates CIITA/MHC II axis and interferon-γ-inducible chemokines in Malassezia globosa-infected keratinocytes.
Luo Y; Tang JF; Gao FF; Quan JH; Ma CT; Li SJ; Fan YM
Mycoses; 2024 Jan; 67(1):e13680. PubMed ID: 38214420
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma.
Wu RS; Kobie JJ; Besselsen DG; Fong TC; Mack VD; McEarchern JA; Akporiaye ET
Cancer Immunol Immunother; 2001 Jul; 50(5):229-40. PubMed ID: 11499806
[TBL] [Abstract][Full Text] [Related]
8. Metabolic instruction of the graft-versus-leukemia immunity.
Burk AC; Apostolova P
Front Immunol; 2024; 15():1347492. PubMed ID: 38500877
[TBL] [Abstract][Full Text] [Related]
9. Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors.
Castiglioni A; Yang Y; Williams K; Gogineni A; Lane RS; Wang AW; Shyer JA; Zhang Z; Mittman S; Gutierrez A; Astarita JL; Thai M; Hung J; Yang YA; Pourmohamad T; Himmels P; De Simone M; Elstrott J; Capietto AH; Cubas R; Modrusan Z; Sandoval W; Ziai J; Gould SE; Fu W; Wang Y; Koerber JT; Sanjabi S; Mellman I; Turley SJ; Müller S
Nat Commun; 2023 Aug; 14(1):4703. PubMed ID: 37543621
[TBL] [Abstract][Full Text] [Related]
10. The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.
Maffini E; Ursi M; Barbato F; Dicataldo M; Roberto M; Campanini E; Dan E; De Felice F; De Matteis S; Storci G; Bonafè M; Arpinati M; Bonifazi F
Front Oncol; 2022; 12():1066285. PubMed ID: 36530990
[TBL] [Abstract][Full Text] [Related]
11. Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis.
Zare S; Kabiri M; Amini Y; Najafi A; Mohammadpour F; Ayati SH; Nikpoor AR; Tafaghodi M
AAPS PharmSciTech; 2021 Dec; 23(1):15. PubMed ID: 34893923
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of relapse and its therapeutic strategies after allogeneic hematopoietic stem cell transplantation].
Wu HW; Zhao YM; Huang H
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):869-877. PubMed ID: 34788930
[No Abstract] [Full Text] [Related]
13. Targeting immunosuppression by TGF-β1 for cancer immunotherapy.
de Streel G; Lucas S
Biochem Pharmacol; 2021 Oct; 192():114697. PubMed ID: 34302795
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cells in Pregnancy: It Is Not All About FoxP3.
Krop J; Heidt S; Claas FHJ; Eikmans M
Front Immunol; 2020; 11():1182. PubMed ID: 32655556
[TBL] [Abstract][Full Text] [Related]
15. Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.
Brentville VA; Metheringham RL; Daniels I; Atabani S; Symonds P; Cook KW; Vankemmelbeke M; Choudhury R; Vaghela P; Gijon M; Meiners G; Krebber WJ; Melief CJM; Durrant LG
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32561639
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment.
Wang H; Zhao S; Zhang X; Jia K; Deng J; Zhou C; He Y
Onco Targets Ther; 2019; 12():7281-7288. PubMed ID: 31564911
[TBL] [Abstract][Full Text] [Related]
18. Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment.
Bernasconi P; Borsani O
J Oncol; 2019; 2019():8323592. PubMed ID: 31485227
[TBL] [Abstract][Full Text] [Related]
19.
Sharbati S; Ravon F; Einspanier R; Zur Bruegge J
Microorganisms; 2019 Feb; 7(3):. PubMed ID: 30818784
[TBL] [Abstract][Full Text] [Related]
20. Comparing Effects of Transforming Growth Factor β1 on Microglia From Rat and Mouse: Transcriptional Profiles and Potassium Channels.
Lively S; Lam D; Wong R; Schlichter LC
Front Cell Neurosci; 2018; 12():115. PubMed ID: 29780305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
